Repligen Corp.

Public bioprocessing company

Appears in 1 story · Last updated Nov 11, 2026

Stories

Freshworks joins S&P SmallCap 600, replacing acquired BioLife Solutions

Money Moves

Acquiring BioLife Solutions; S&P MidCap 400 constituent

Freshworks joined the S&P SmallCap 600 on October 8, taking the seat BioLife Solutions gave up as Repligen buys it for about $1.5 billion. The stock hit a 52-week high of $13.99 on October 6 as index funds bought ahead of the switch.

Updated Yesterday